Cannabinoids in Medicine: Limitless Hope or Hype?

What is the role of cannabinoids as an intoxicant and in medical applications today? This was the question addressed by Dieter Braus, MD, psychiatrist and neurologist at Vitos Clinic Rheingau in Eltville, Germany, at the DGIM Congress 2022. Dampening the Dopamine System Regardless of the type of substance-dependent addiction — whether alcohol, opiates, nicotine, or … Read more

Novel Drug Significantly Reduces Tics ― Without Side Effects

An investigational drug that blocks the dopamine-1 (D1) receptor reduces tics and is safe and well tolerated in children with Tourette syndrome (TS), a new study shows. Importantly, current medications for the disorder, ecocipam does not lead to weight gain, anxiety, depression, or tardive dyskinesia compared to placebo ― a factor that may lead to … Read more

Tourette Patients Vulnerable to Assault, Criminal Behavior

Patients with Tourette syndrome (TS) are more likely to be assaulted or to perpetrate a crime, new research shows. Results of a large study show that compared to the general population, patients with TS were twice as likely to be assaulted and three times more likely to commit a crime. However, study investigator David Mataix-Cols, … Read more

‘Robust’ Increase in Tics During the Pandemic Explained?

Updated March 4, 2022 // Editor’s note: This story has been updated with additional comments from Davide Martino, MD, PhD, of the University of Calgary, Canada. Early results from a new study show a significant correlation between tic initiation and social media use during the COVID pandemic in adolescents with a preexisting tic disorder. Dr … Read more